touchPODCAST

touchMDT for touchCARDIO

Listen to key experts from a multidisciplinary team, plus a patient with HFrEF, discuss the role of the multidisciplinary team in managing patients with HF

The multidisciplinary team

• Cardiologist: Dr Akshay Desai, Boston, USA

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Merck & Co., Inc., Boehringer Ingelheim Pharmaceuticals Inc. (BIPI) and Lilly USA, LLC (Lilly) Alliance. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchcardioime.org/multidisciplinary-team-insights-on-the-promise-of-new-and-emerging-treatment-options-for-patients-with-hfref//

touchMDT for touchIMMUNOLOGY

Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.

The multidisciplinary team

• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management

touchMDT for touchIMMUNOLOGY

Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.

The multidisciplinary team

• Dermato-oncologist: Dr Joël Claveau, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management

touchMDT for touchIMMUNOLOGY

Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.

The multidisciplinary team

• Radiation oncologist: Dr Agata Rembielak, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management

touchMDT for touchIMMUNOLOGY 

Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.

The multidisciplinary team

• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.com/mdt-optimizing-cscc-management

touchMDT for touchONCOLOGY

Listen in as a dermatologist, a dermatopathologist, a radiation oncologist and a head and neck surgeon discuss the role of the multidisciplinary team in the care of patients with CSCC and how effective collaboration can improve outcomes for these patients.

The multidisciplinary team

• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management

touchMDT for touchONCOLOGY

Listen in as a dermato-oncologist and a dermatologist consider when to use systemic therapies to treat patients with locally advanced or metastatic CSCC, using a patient case to illustrate the emerging role of immunotherapy in clinical practice.

The multidisciplinary team

• Dermato-oncologist: Dr Joël Claveau, Canada

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management

touchMDT for touchONCOLOGY

Listen to a radiation oncologist and a head and neck surgeon discuss the considerations to assess eligibility for surgery and/or radiotherapy in patients with a confirmed diagnosis of CSCC, illustrated using a patient case.

The multidisciplinary team

• Radiation oncologist: Dr Agata Rembielak, UK

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management  

touchMDT for touchONCOLOGY

Listen to a dermatologist and a dermatopathologist discuss the key recommendations for the diagnostic workup of patients with suspected CSCC, and consider how to accurately assess prognostic factors while identifying the key stakeholders involved in this crucial stage in the patient’s journey.

The multidisciplinary team

• Dermatologist: Prof. Caroline Robert, France

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchoncologyime.com/mdt-optimizing-cscc-management  

touchMDT for touchNEUROLOGY

Listen to an SMA specialist, a physical therapist and two adult patients talk about the role of the multidisciplinary team in maintaining quality of life in patients with SMA     

The multidisciplinary team

• SMA Specialist: Dr Claudia Chiriboga, New York, NY USA

This touchPODCAST is for HCPs only. 

This activity is funded by an unrestricted independent medical educational grant from Genentech, a member of the Roche group, and Novartis Gene Therapies, Inc. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchneurology.com/cme/later-onset-SMA-quality-of-life/